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Abstract
Background: Brazilian propolis type 6 (Atlantic forest, Bahia) is distinct from the other types of propolis
especially due to absence of flavonoids and presence of other non-polar, long chain compounds, but
presenting good in vitro and in vivo antimicrobial activity. Several authors have suggested that fatty acids
found in this propolis might be responsible for its antimicrobial activity; however, so far no evidence
concerning this finding has been reported in the literature. The goals of this study were to evaluate the
antibacterial activity of the main pure fatty acids in the ethanolic extract and fractions and elucidate the
chemical nature of the bioactive compounds isolated from Brazilian propolis type 6.
Methods: Brazilian propolis type 6 ethanolic extract (EEP), hexane fraction (H-Fr), major fatty acids, and
isolated sub-fractions were analyzed using high performance liquid chromatography (HPLC), high
resolution gas chromatography with flame ionization detection (HRGC-FID), and gas chromatography-
mass spectrometry (GC-MS). Three sub-fractions of H-Fr were obtained through preparative HPLC.
Antimicrobial activity of EEP, H-Fr, sub-fractions, and fatty acids were tested against Staphyloccus aureus
ATCC 25923 and Streptococcus mutans Ingbritt 1600 using minimum inhibitory concentration (MIC) and
minimum bactericidal concentration (MBC).
Results: EEP and H-Fr inhibited the growth of the microorganisms tested; nevertheless, no antimicrobial
activity was found for the major fatty acids. The three sub-fractions (1, 2, and 3) were isolated from H-Fr
by preparative HPLC and only sub-fraction 1 showed antimicrobial activity.
Conclusion: a) The major fatty acids tested were not responsible for the antimicrobial activity of propolis
type 6; b) Sub-fraction 1, belonging to the benzophenone class, was responsible for the antimicrobial
activity observed in the present study. The identification of the bioactive compound will improve the
development of more efficient uses of this natural product.
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Background
Propolis, a non-toxic resinous hive product collected by
Apis mellifera bees from various plant sources, has been
reported to have several properties that may confer health
benefits to humans since ancient times [1,2]. Propolis
chemical composition and pharmacological activity
might vary significantly depending on its geographic ori-
gin and seasonal effect [3-6]. Furthermore, its chemical
composition is extremely complex and its flavonoids and
(hydroxyl) cinnamic acid derivatives have been widely
cited as its biologically active compounds [7-9]. Although
these compounds have not been detected in propolis clas-
sified as type 6 (from the Atlantic forest, Northeastern Bra-
zil) [10,11], its ethanolic extract and hexane fractions (H-
Fr) have shown remarkable antimicrobial activities
against pathogens, including mutans streptococci [11-13].
It has been proposed that the antimicrobial activity of
type-6 propolis might be due to a high proportion of fatty
acids (oleic, palmitic, linoleic, and stearic) identified as
part of its chemical composition [13]; nonetheless, such
compounds (fatty acids) have not been tested. Therefore,
the goals of the present study were to evaluate the antibac-
terial activity of the main pure fatty acids found in the eth-
anolic extract and fractions of Brazilian propolis type 6, as
well as to elucidate the chemical nature of the bioactive
compounds isolated from it.
Methods
Propolis samples and fractionation
Crude samples of Apis mellifera propolis, originated from
the Atlantic forest region, state of Bahia, SL 11°56'31 and
WL 38°05'04, in the Northeastern Region of Brazil, classi-
fied as propolis type 6 [10] and botanically originated
from Hyptis divaricata [3], were acquired in May 2006. The
ethanolic extract of propolis (EEP) at 20% (w/v) was pre-
pared using aqueous ethanol (80% v/v) according to the
literature [13]. The EEP was further fractioned using a liq-
uid-liquid extraction technique with hexane to generate a
polar fraction (P-Fr) and H-Fr. The purification grade of
the EEP and its fractions was monitored by thin layer
chromatography (TLC) using the anisaldehyde reagent (4-
methoxy-benzaldehyde, acetic acid, sulfuric acid –
1.0:48.5:0.5), followed by incubation at 100°C for 5 min.
Substances were visualized under ultraviolet (UV) light at
the wavelengths of 254 nm and 366 nm [6,14]. The EEP,
H-Fr, and P-Fr were concentrated in a rotaevaporator at
45°C and yielded 58% (w/w), 14% (w/w), and 11% (w/
w), respectively.
Analytical and preparative HPLC analysis
A Shimadzu Prep 6AD LC system equipped with a SPD-
M10Avp photodiode array detector (PDA), an auto injec-
tor 10AF, and a fraction collector FRC-10A, was used to
perform the HPLC analysis. For the analytical test, diluted
solutions of EEP, fractions (H-Fr and P-Fr), and isolated
sub-fractions (1, 2, and 3) (1 mg/100 mL) were filtered
(Millipore – 0.22 μm), and 10 μL aliquots were injected in
a Shimadzu reverse-phase analytical column of 250 mm ×
4.6 mm (i.d.) × 5 μm (particle size). For the mobile phase,
we used water (solvent A) and methanol (solvent B) at a
constant flow rate of 1 mL/min. The gradient started with
80–90% for solvent B at 15 min returning to 80% at 30
min. All sub-fractions were detected according to charac-
teristic UV-vis spectra (spectral range of 200–450 nm) and
retention times. Preparative HPLC was carried out using a
preparative column Shimadzu PREP-ODS (H) (250 mm ×
20 mm – i.d). To isolate the sub-fractions, a gradient using
both solvents was used at room temperature with a flow
rate of 8 mL/min [6]. Three sub-fractions were isolated
from H-Fr.
High resolution gas chromatography with flame ionization 
detection (HRGC-FID)
Fatty acid methyl esters (FAMEs) were prepared from EEP,
its fractions and sub-fractions according to a modification
of the method by Hartman and Lago (1973) [15]. Sam-
ples of 0.3 μL were injected into a Hewlett-Packard (HP)
5890 series II gas chromatographer equipped with a 60 m
DB-23 (0.25 mm I.D., 0.25 μm film thickness) column.
The oven temperature was programmed as follows:
130°C (1.0 min) to 170°C (6.5°C/min), 170°C to
215°C (2.75°C/min), 215°C (12 min), 215°C to 230°C
(40°C/min), and 230°C (3 min). The injector and detec-
tor were used at 270°C and 280°C, respectively. FAMEs
were identified using standard of fatty acids (Sigma, St
Louis, MO, USA) with 6, 8, 10, 12, 14, 15, 16 (cis e trans),
17, 18 (cis e trans), 20, 22, and 24 atoms of carbon, satu-
rated and unsaturated and helium (He) was used as the
carrier gas (1.0 mL/min).
Gas chromatography-mass spectrometry (GC-MS)
The analyses of fatty acid were performed after methyla-
tion of the EEP, its fractions, and sub-fractions as
described in the literature [16]. Aliquots of 400 μL (10
mg/mL) of the samples were placed into glass vials and
400 μL of CH2N2 were added to each solution. All the
samples were refrigerated for 4 h to allow complete meth-
ylation and then analyzed by GC-MS using a CBP5 col-
umn (30 m × 0.25 mm i.d.) installed in a GC 17A
(Shimadzu Co.) instrument interfaced with a QP 5000
mass selective detector operated in scanning mode (m/z
40–400). For GC-MS analysis, the temperature was set
from 50°C (0.3 min hold) to 285°C (15 min hold) at a
rate of 6°C/min. The samples were injected with an AOC-
17 autoinjector using a splitless injection technique (0.6
μL injection volume) and He flow was set at 1.0 mL/min.
The GC-MS peaks were identified by comparison with
data found in the literature and characterized using the
library search software of Shimadzu Class-Vp (Wiley 138
and Nist 98 databases).
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Microbial susceptibility testing
The minimum inhibitory concentration (MIC) and mini-
mum bactericidal concentration (MBC) of the EEP, frac-
tions, pure fatty acids, and isolated sub-fractions were
evaluated to determine their antimicrobial activity using
Streptococcus mutans Ingbritt 1600 and Staphylococcus
aureus ATCC 25923, based on previously published meth-
odology [12,13]. To determine MIC we used inoculums of
5 × 105 CFU/mL, concentrations of EEP, fractions, and
pure fatty acids ranging from 6.25 to 1600 μg/mL, and
concentration of isolated sub-fractions ranging from 0.2
to 210 μg/mL. To determine MBC, aliquots of 20 μL of all
incubated tubes with concentrations higher than the MIC
were subcultured on BHI agar and supplemented with 5%
defibrinated sheep blood using a spiral plater (Whittley
Automatic Spiral Plater) [12]. All these analyses were per-
formed in triplicate. We used ethanol (final ethanol con-
centration: 0.6%, v/v) as the control vehicle and
digluconate chlorhexidine 0.12% (Sigma®) as positive
control in both tests.
Results and Discussion
Table 1 shows MIC and MBC values for EEP, H-Fr, and P-
Fr, respectively. MIC values indicated that the H-Fr exhib-
ited strong antibacterial activity against S. aureus and S.
mutans, with concentrations as low as 25 μg/mL and 50
μg/mL, respectively. Similar results were found in other
studies for S. mutans Ingbritt 1600 [12,13], but no data
concerning antimicrobial activity of EEP and its fractions
against S. aureus were available in the literature. The H-Fr
showed lower values than the other samples and this find-
ing indicated the presence of an active compound in this
fraction. However, MIC and MBC values for EEP, H-Fr,
and P-Fr were higher than that found for the positive con-
trol (chlorhexidine 0.12%). This might be explained by
the fact that a synthetic pure mono-drug (chlorhexidine)
was compared with the fractions of a natural product that
presents its biological compound diluted in the samples
(EEP, H-Fr, or P-Fr).
HPLC analyses of EEP and H-Fr demonstrated identical
chemical profiles for both, since they presented three
chemical peaks in common and in similar proportions
(Figure 1) and neither flavonoids nor cinnamic acid deriv-
atives were detected.
EEP and H-Fr chemical compositions were analyzed by
HRGC-FID and GC-MS, and high and similar concentra-
tions of fatty acids were observed, which is corroborated
RP-HPLC Chromatograms of propolis type 6Figure 1
RP-HPLC Chromatograms of propolis type 6. (A) Eth-
anolic extract of propolis (EEP) and (B) hexane fractions (H-
Fr). Peaks 1, 2, and 3 have the same retention time in both A 
and B graphics.
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Table 1: Minimum inhibitory concentration (MIC) and minimum bacterial concentration (MBC) of different fractions against 
Staphylococcus aureus ATCC 25923 and Streptococcus mutans Ingbritt 1600.
Sample Staphylococcus aureus ATCC 25923 Streptococcus mutans Ingbritt 1600
MIC (μg/mL) MBC (μg/mL) MIC (μg/mL) MBC (μg/mL)
EEP 25–50 400–800 50–100 > 1600
H-Fr 25–50 200–400 50–100 800–1600
P-Fr 50–100 400–800 100–200 > 1600
Positive Control* 1.5–3.1 3.1–6.25 0.75–1.5 1.5–3.1
*Positive Control: digluconate chlorhexidine 0.12% – Sigma®.
ND: not determined.
Experiments carried out in triplicate.
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by previous findings (Table 2) [12,13]. We identified the
following fatty acids: oleic (18:1), palmitic (16:0), linoleic
(18:2), and stearic (18:0), present in higher concentra-
tions in EEP and H-Fr, as already shown in previous stud-
ies [12,13]. Based on previous studies showing similar
results [17-19], some authors suggested that the chemical
composition of this propolis might be responsible for its
antimicrobial activity [12,13].
The same fatty acids (oleic, palmitic, linoleic, and stearic
acid – Sigma®), tested isolatedly or mixed, showed no bac-
terial activity against Gram-positive bacteria (S. aureus or
S. mutans) at concentrations lower than 1600 μg/mL.
However, MIC values found for H-Fr were lower than 50
and 100 μg/mL for S. aureus and S. mutans, respectively
(Table 1), suggesting that other compounds, different
from the fatty acids tested, might account for the antimi-
crobial activity detected in the present study.
Since no satisfactory MIC and MBC results were found for
the fatty acids tested, three unpurified sub-fractions were
isolated from H-Fr by means of preparative HPLC and
tested, isolatedly or mixed, for antibacterial activity. Only
sub-fraction 1 (peak 1, Figure 1B) showed satisfactory
antibacterial activity against S. aureus and S. mutans, with
MIC ranging from 1.56 to 3.12 and 3.12 to 6.2 μg/mL,
respectively (Table 3), but the mixture of these three sub-
fractions showed no bacterial activity. This might have
happened due to the dilution of the active compounds
present in sub-fraction 1, thus excluding the possibility of
any synergistic effects of these three sub-fractions.
MIC values found for sub-fraction 1 were similar to those
obtained for the positive control (chlorhexidine 0.12%)
for both microorganisms tested, suggesting that sub-frac-
tion 1 might contain an antimicrobial bioactive com-
pound. In addition, since chlorhexidine, a pure mono-
drug, and sub-fraction 1, an impure bioactive compound,
showed similar MIC results, we might speculate that this
compound could be a promising antimicrobial agent,
which needs to be isolated and identified. TLC and HPLC
analyses of sub-fraction 1 showed a mixture of non-polar
compounds; however, when this sub-fraction was ana-
lyzed by HRGC-FID, no fatty acid characteristics were
found (Figure 2). Furthermore, when sub-fraction 1 was
analyzed by PDA detector, two maximum absorbance val-
ues were found (240 nm and 300 nm), which is character-
istic of benzophenone compounds [20,21]. GC-MS
analyses showed fragments at m/z 105, indicating that
this sub-fraction belongs to the benzophenone class and
is not a fatty acid, as suggested in the literature [10,12,13].
Fragments at m/z 77, 69, and 55 showed its prenylated
nature (Figure 3) and those at m/z 433 and 309 confirmed
that this is a polyprenylated benzophenone [21].
Benzophenones are among the most important chemical
compounds identified and isolated from propolis found
in tropical regions [20-23]. They have been reported as
Table 3: Minimum inhibitory concentration (MIC) and minimum bacterial concentration (MBC) of three isolated sub-fractions against 
Staphylococcus aureus ATCC 25923 and Streptococcus mutans Ingbritt 1600.
Sample Staphylococcus aureus ATCC 25923 Streptococcus mutans Ingbritt 1600
MIC (μg/mL) MBC (μg/mL) MIC (μg/mL) MBC (μg/mL)
Sub-fraction 1 1.5–3.1 26–53 3.1–6.25 53–106
Sub-fraction 2 > 210 > 210 > 210 > 210
Sub-fraction 3 > 210 > 210 > 210 > 210
Positive control* 1.5–3.1 3.1–6.25 0.75–1.5 1.5–3.1
*Positive control: digluconate chlorhexidine 0.12% – Sigma®.
Experiments carried out in triplicate.
Table 2: Chemical composition of fatty acids of EEP and H-Fr from Brazilian propolis type 6 obtained by HRGC-FID and GC-MS.
Retention time (min) Carbon saturation* Fatty acid EEP (%) H-Fr (%)
3.03 10:0 capric acid 4.61 traces
13.39 16:0 palmitic acid 29.05 35.44
17.37 18:0 estearic acid 3.12 4.41
17.59 18:1 oleic acid 55.72 50.33
18.54 18:2 linoleic acid 3.74 5.51
20.23 18:3 Alpha linolenic acid 1.47 1.98
21.28 22:0 behenic acid 2.29 2.33
*10:0 = decanoic acid; 16:0 = n-dodecanoic acid; 18:0 = n-octadecanoic acid; 18:1 = cis-9-octadecenoic acid; 18:2 = cis-9.12-octadecadienoic acid; 
18:3 = cis-9.12.15-octadecatrienoic acid; 22:0 = docosanoic acid.
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having various biological activities, such as potential anti-
microbial activity against both Gram-positive and Gram-
negative bacteria [22-27].
Conclusion
No antimicrobial activity was observed for the main fatty
acids identified in Brazilian propolis type 6. Sub-fraction
1 isolated from this type of propolis belongs to the benz-
ophenone class and was responsible for the antimicrobial
activity observed in the present study. The identification
of this bioactive compound will improve the develop-
ment of more efficient uses of this natural product.
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